Osman Faheem

Suggest Changes

Writes About:

Learn More
BACKGROUND Two recent meta-analyses demonstrated that angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) reduce the risk of developing new-onset atrial(More)
  • 1